EuroIntervention PCRonline - Connecting with the community

Just accepted article

Drug-eluting stents versus bare-metal stents for the prevention of restenosis in patients with renovascular disease


As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers. To read the full content of this article, please download the PDF.



Aims:To assess the impact of drug-eluting stents (DES) compared to bare-metal stents (BMS) for the endovascular treatment of atherosclerotic renal artery stenosis (ARAS).

Methods: We retrospectively evaluated all of our endovascular BMS- and DES-implantations performed in de-novo ARAS between 2000-2014 at our institution. The occurrence of in-stent restenosis (ISR) detected by ultrasound or angiography, kidney function, blood pressure (BP), and the number of antihypertensive drugs were analyzed as endpoints.

Results: Overall, 338 renal arteries were treated in 298 patients. BMS…

– OR –